GeneDx Holdings (WGS) Other Working Capital Changes (2020 - 2026)

GeneDx Holdings (WGS) has reported Other Working Capital Changes for 7 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Working Capital Changes rose 49.14% year-over-year to $1.1 million in Q2 2026; TTM through Jun 2026 was $3.8 million, a 24.55% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, down 3.77% from the prior year.
• Other Working Capital Changes was $1.1 million for Q2 2026 at GeneDx Holdings, up from $1.0 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $12.0 million in Q2 2025 and troughed at -$10.7 million in Q3 2025.
• A 5-year average of $752055.6 and a median of -$114000.0 in 2022 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes surged 640.82% in 2022 and plunged 150.89% in 2023, its largest moves.
• Over 5 years, Other Working Capital Changes stood at $7.9 million in 2022, then sank by 150.89% to -$4.0 million in 2023, then surged by 116.13% to $648000.0 in 2024, then climbed by 20.52% to $781000.0 in 2025, then soared by 43.79% to $1.1 million in 2026.
• The last three Other Working Capital Changes figures came in at $1.1 million (Q2 2026), $1.0 million (Q1 2026), and $781000.0 (Q4 2025), per Business Quant data.